Clinical trial
Molecular Analysis of Nucleic Acids Derived From Patients With Neuromuscular Disease and Their Family Members
NCT00390104 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Analysis of Nucleic Acids Derived From Patients With Neuromuscular Disease and Their Family Members
- Lead sponsor
- Boston Children's Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 31, 2002
- Completion date
- December 31, 2027
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
duchenne/becker muscular dystrophy, limb-girdle muscular dystrophy, neuromuscular; disorder, hereditary